Aarti Drugs Q2 FY27 Earnings Shine As Profit Nearly Doubles To ₹82.8 Crore, Revenue Rises 27% To ₹828.8 Crore While 63% EBITDA Growth Signals Stronger Operating Performance
Mumbai: Aarti Drugs reported strong financial results for the second quarter of FY27, with profit after tax (PAT) rising approximately 83 per cent year-on-year to ₹82.8 crore, compared with ₹45.2 crore in the corresponding quarter last year. Revenue from operations increased 27 per cent to ₹828.8 crore during the July-September quarter, against ₹652.9 crore in Q2 FY26. The pharmaceutical company…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
